Entity coverage

Sage Therapeutics, Inc.

SAGE · 4 events mapped

Market Ontology has mapped 4 distinct macro, policy, and market events to SAGE. Each entry below traces the causal channel from the driver to the assumption it moved.

Recent event impacts

Full ledger →
  • 2026-06-29EventIndirect competitive pressure or validation of gene therapy approach for neurological disorders. While not directly competitive for Rett Syndrome, success in gene therapy for neurological conditions can influence investor sentiment across the sub-sector.
  • 2026-06-29EventIndirect competitive pressure or market validation for gene therapies targeting neurological disorders, specifically Rett syndrome.
  • 2026-06-22EventIndirect competitive pressure in the neurological disorder space, particularly for rare diseases affecting children.
  • 2026-06-22EventWhile not directly competitive with TSHA-102, success in gene therapy for neurological disorders like Rett syndrome could validate the broader market for advanced therapies in this space, potentially attracting more investment and research, which could indirectly benefit other companies developing t

Continuous coverage for SAGE with alerts, structural playbooks, and options routing lives in the platform. Start a trial →